Vai trò của miR-1 và miR-133a trong hậu điều kiện thiếu máu cơ tim
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cokkinos DV, Pantos C: Myocardial protection in man--from research concept to clinical practice. Heart Fail Rev. 2007, 12: 345-362. 10.1007/s10741-007-9030-5.
Wu HH, Hsiao TY, Chien CT, Lai MK: Ischemic conditioning by short periods of reperfusion attenuates renal ischemia/reperfusion induced apoptosis and autophagy in the rat. J Biomed Sci. 2009, 16: 19-10.1186/1423-0127-16-19.
Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 1986, 74: 1124-1136.
Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003, 285: H579-H588.
Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, Kerendi F, Guyton RA, Vinten-Johansen J: Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004, 62: 74-85. 10.1016/j.cardiores.2004.01.006.
Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M: Postconditioning inhibits mitochondrial permeability transition. Circulation. 2005, 111: 194-197. 10.1161/01.CIR.0000151290.04952.3B.
Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, Andre-Fouet X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M: Long-term benefit of postconditioning. Circulation. 2008, 117: 1037-1044. 10.1161/CIRCULATIONAHA.107.729780.
Vinten-Johansen J: Postconditioning: A mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion. Heart Fail Rev. 2007, 12: 235-244. 10.1007/s10741-007-9024-3.
Lin XM, Zhang ZY, Wang LF, Zhang L, Liu Y, Liu XL, Yang XC, Cui L: Attenuation of tumor necrosis factor-alpha elevation and improved heart function by postconditioning for 60 seconds in patients with acute myocardial infarction. Chin Med J (Engl). 2010, 123: 1833-1839.
Li Y, Ge X, Liu X: The cardioprotective effect of postconditioning is mediated by ARC through inhibiting mitochondrial apoptotic pathway. Apoptosis. 2009, 14: 164-172. 10.1007/s10495-008-0296-4.
Fang J, Wu L, Chen L: Postconditioning attenuates cardiocyte ultrastructure injury and apoptosis by blocking mitochondrial permeability transition in rats. Acta Cardiol. 2008, 63: 377-387. 10.2143/AC.63.3.1020316.
Penna C, Perrelli MG, Raimondo S, Tullio F, Merlino A, Moro F, Geuna S, Mancardi D, Pagliaro P: Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts. Biochim Biophys Acta. 2009, 1787: 794-801. 10.1016/j.bbabio.2009.03.013.
Zhao WS, Xu L, Wang LF, Zhang L, Zhang ZY, Liu Y, Liu XL, Yang XC, Cui L: A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction. Apoptosis. 2009, 14: 1204-1211. 10.1007/s10495-009-0387-x.
Bostjancic E, Zidar N, Stajer D, Glavac D: Micrornas mir-1, mir-133a, mir-133b and mir-208 are dysregulated in human myocardial infarction. Cardiology. 2010, 115: 163-169. 10.1159/000268088.
Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z, Yang B: The muscle-specific micrornas mir-1 and mir-133 produce opposing effects on apoptosis by targeting hsp60, hsp70 and caspase-9 in cardiomyocytes. J Cell Sci. 2007, 120: 3045-3052. 10.1242/jcs.010728.
Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, Pritchard TJ, Fan GC: Microrna-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation. 2009, 119: 2357-2366. 10.1161/CIRCULATIONAHA.108.814145.
Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner DE, Vatner SF, Abdellatif M: Downregulation of mir-199a derepresses hypoxia-inducible factor-1alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res. 2009, 104: 879-886. 10.1161/CIRCRESAHA.108.193102.
Zhuo Y, Chen PF, Zhang AZ, Zhong H, Chen CQ, Zhu YZ: Cardioprotective effect of hydrogen sulfide in ischemic reperfusion experimental rats and its influence on expression of survivin gene. Biol Pharm Bull. 2009, 32: 1406-1410. 10.1248/bpb.32.1406.
Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Sellke FW: The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg. 2008, 33: 906-913. 10.1016/j.ejcts.2008.01.047.
Lee AS, Su MJ: Comparison of the cardiac effects between quinazoline-based alpha1-adrenoceptor antagonists on occlusion-reperfusion injury. J Biomed Sci. 2008, 15: 239-249. 10.1007/s11373-007-9214-y.
Shyu KG, Liang YJ, Chang H, Wang BW, Leu JG, Kuan P: Enhanced expression of angiopoietin-2 and the Tie2 receptor but not angiopoietin-1 or the Tie1 receptor in a rat model of myocardial infarction. J Biomed Sci. 2004, 11: 163-171. 10.1007/BF02256559.
Yin C, Salloum FN, Kukreja RC: A novel role of microrna in late preconditioning: Upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circ Res. 2009, 104: 572-575. 10.1161/CIRCRESAHA.108.193250.
Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S: Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem. 1992, 267: 10551-10560.
Zhou X, Sheng Y, Yang R, Kong X: Nicotine promotes cardiomyocyte apoptosis via oxidative stress and altered apoptosis-related gene expression. Cardiology. 2010, 115: 243-250. 10.1159/000301278.
Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH: Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg. 2005, 18: 335-350. 10.1080/08941930500328862.
Kumar P, Coltas IK, Kumar B, Chepeha DB, Bradford CR, Polverini PJ: Bcl-2 protects endothelial cells against gamma-radiation via a raf-mek-erk-survivin signaling pathway that is independent of cytochrome c release. Cancer Res. 2007, 67: 1193-1202. 10.1158/0008-5472.CAN-06-2265.
Lalier L, Cartron PF, Juin P, Nedelkina S, Manon S, Bechinger B, Vallette FM: Bax activation and mitochondrial insertion during apoptosis. Apoptosis. 2007, 12: 887-896. 10.1007/s10495-007-0749-1.
Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT: Altered microrna expression in human heart disease. Physiol Genomics. 2007, 31: 367-373. 10.1152/physiolgenomics.00144.2007.
Salloum FN, Yin C, Kukreja RC: Role of miRs in Cardiac Preconditioning. J Cardiovasc Pharmacol. 2010,
Yin C, Wang X, Kukreja RC: Endogenous micrornas induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice. FEBS Lett. 2008, 582: 4137-4142. 10.1016/j.febslet.2008.11.014.
Bostjancic E, Zidar N, Glavac D: Microrna microarray expression profiling in human myocardial infarction. Dis Markers. 2009, 27: 255-268.
Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN: An intragenic mef2-dependent enhancer directs muscle-specific expression of micrornas 1 and 133. Proc Natl Acad Sci USA. 2007, 104: 20844-20849. 10.1073/pnas.0710558105.
Horie T, Ono K, Nishi H, Iwanaga Y, Nagao K, Kinoshita M, Kuwabara Y, Takanabe R, Hasegawa K, Kita T, Kimura T: Microrna-133 regulates the expression of glut4 by targeting klf15 and is involved in metabolic control in cardiac myocytes. Biochem Biophys Res Commun. 2009, 389: 315-320. 10.1016/j.bbrc.2009.08.136.
Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z: Down-regulation of mir-1/mir-133 contributes to re-expression of pacemaker channel genes hcn2 and hcn4 in hypertrophic heart. J Biol Chem. 2008, 283: 20045-20052. 10.1074/jbc.M801035200.